Your session is about to expire
← Back to Search
Virus Therapy
HPV Self-sampling to Improve Access to Cervical Cancer Screening for Persons With HIV and/or Underserved Individuals (ACCESS Trial)
N/A
Waitlist Available
Led By Darcy Rao, PhD, MPH
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during study year 1
Awards & highlights
No Placebo-Only Group
Summary
This trial is evaluating whether self-collection of vaginal samples for HPV testing is an effective alternative cervical cancer screening strategy for persons with HIV and/or limited access to care.
Eligible Conditions
- Cervical Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ during study year 1
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during study year 1
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Confidence with self-collection
Ease of returning home kits
Proportion of eligible individuals who accept self-sampling kits
+3 moreSecondary study objectives
Attitudes and preferences for screening
Colposcopy results checklist
HPV prevalence checklist
+6 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: HPV self-samplingExperimental Treatment1 Intervention
Participants will be offered self-collection kits for HPV-based cervical cancer screening.
Find a Location
Who is running the clinical trial?
University of WashingtonLead Sponsor
1,824 Previous Clinical Trials
1,913,305 Total Patients Enrolled
National Center for Advancing Translational Sciences (NCATS)NIH
374 Previous Clinical Trials
409,232 Total Patients Enrolled
Darcy Rao, PhD, MPHPrincipal InvestigatorUniversity of Washington